Clinical Trial

A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis

Name: A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis — clinical trial record (NCT07709910)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The study is being conducted to evaluate the efficacy and safety of Ribupatide Injection in participants with obesity and knee osteoarthritis, and to explore its improvement on knee joint structure.

Trial Details

NCT Number	NCT07709910
Lead Sponsor	Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions	Participants With Obesity and Knee Osteoarthritis
Enrollment	382 participants
Start Date	2026-07
Primary Completion	2028-11 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-17